The global pharmaceutical industry experienced a 59% decline in the number of environmental sustainability-related patent applications in Q2 2024 compared with the previous quarter. The total number of environmental sustainability-related grants dropped by 18% in Q2 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook Pharma: Patents Trends Q2 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of environmental sustainability-related patent applications in the pharmaceutical industry was 2,856 in Q2 2024, versus 6,946 in the prior quarter.
The top five companies accounted for 3% of patenting activity
Analysis of patenting activity by companies shows that Roche filed the most environmental sustainability patents within the pharmaceutical industry in Q2 2024. The company filed 29 environmental sustainability-related patents in the quarter, compared with 24 in the previous quarter. It was followed by Chinese Academy of Sciences with 17 environmental sustainability patent filings, Johnson & Johnson (16 filings), and Contemporary Amperex Technology (16 filings) in Q2 2024.
Patenting activity was driven by China with a 23% share of total patent filings
The largest share of environmental sustainability related patent filings in the pharmaceutical industry in Q2 2024 was in China with 23%, followed by the US (20%) and Japan (9%). The share represented by China was 31% lower than the 54% share it accounted for in Q1 2024.
For further understanding of GlobalData's Pharma: Patents Trends Q2 2024, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.